Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Long-Term Deferred Tax (2016 - 2023)

Biomerica's Long-Term Deferred Tax history spans 11 years, with the latest figure at $8.1 million for Q1 2023.

  • On a quarterly basis, Long-Term Deferred Tax changed N/A to $8.1 million in Q1 2023 year-over-year; TTM through Feb 2023 was $8.1 million, a N/A change, with the full-year FY2022 number at $7.0 million, changed N/A from a year prior.
  • Long-Term Deferred Tax hit $8.1 million in Q1 2023 for Biomerica, up from $7.7 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for BMRA hit a ceiling of $8.1 million in Q1 2023 and a floor of $10000.0 in Q1 2019.
  • Historically, Long-Term Deferred Tax has averaged $6.0 million across 3 years, with a median of $7.4 million in 2022.